Story
In the build up to Breast Cancer Awareness month in October, I'll be taking on two sporting events to raise money for Lobular Breast Cancer UK, the type of breast cancer I was diagnosed with.
My first sprint triathlon will be happening on the 31st August followed by the 2 mile Swim Serpentine on the 20th September.
I've been hesitant to set up this page as I'm feeling distinctly unsporty in the build up to the events. I'm a year free from surgery, chemotherapy and radiation but the post-cancer fatigue is real, not helped by the continuing medication I'm on for a while. So, some days I feel confident and others not so much. Every day is different and I just hope that on these two days, adrenalin will carry me over the finish line.
For the Shropshire triathlon, I'm joined by my incredible friend Benna Waites. We completed the 1 mile Swim Serpentine event a few years ago and then, as fate would have it, we were both diagnosed with breast cancer within a year of each other (could it be the dodgy Serpentine?!) Andy will also be joining for the triathlon so you'll be supporting him as well! We'll be doing a 750m swim, a 25k bike ride and a 5k run.
For Swim Serpentine, I'll be out there on my own, so hoping I can just keep afloat. There are no PBs to beat here, just the will to make it over the line. If it doesn't take all day and they don't have to scoop me up, that would be ideal. It will obviously mean so much to try and complete these events after a long time struggling with the physical and mental challenges of breast cancer treatment and recovery.
More about Lobular Breast Cancer:
At LBCUK we work to save more lives by unlocking the challenge that is lobular breast cancer.
Lobular Breast Cancer UK is a patient advocacy charity working to ensure that everyone diagnosed with lobular breast cancer lives and lives well. Lobular makes up 15% of all breast cancers diagnosed and rarely forms a lump due to its unique growing pattern making it hard to see on scans. More research is needed into this specific breast cancer which is often diagnosed at a later stage due to its ‘hard to see’ nature.